secwatch.observer — SEC 8-K summary
======================================

Issuer:     Aptevo Therapeutics Inc. (APVO)
CIK:        0001671584
Form:       8-K
Filed at:   2022-11-04T23:59:59+00:00
Accession:  0001564590-22-036769
Event type: other_material
Sentiment:  neutral
Materiality: 0.10
Item codes: 1.01, 3.03, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Aptevo extends shareholder rights plan expiration to November 4, 2023
---------------------------------------------------------------------

- Amendment No. 2 to Rights Agreement extends Final Expiration Date to Nov 4, 2023.
- Rights Agreement originally dated Nov 8, 2020, amended Nov 5, 2021, and now Nov 4, 2022.
- Rights pertain to contingent purchase of one one-thousandth of Series A Junior Participating Preferred Stock.
- Broadridge Corporate Issuer Solutions remains Rights Agent.
- No changes to other terms or exercise price of rights.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1671584/000156459022036769/0001564590-22-036769-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1671584/000156459022036769/apvo-8k_20221104.htm
  HTML page:      https://secwatch.observer/filing/0001564590-22-036769

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer